BACKGROUND Pheochromocytoma is associated with catecholamine-induced cardiac toxicity, but the extent and
and heart failure (4-6). Various cardiac pathologies have been described, including cardiac hypertrophy, stress-induced cardiomyopathy, myocarditis, systolic and diastolic dysfunction, and dilated cardiomyopathy (4-7). Further, catecholamines have been shown to influence the extracellular matrix with collagen deposition and subsequent fibrosis in the myocardium (6, 8) . These changes are beyond hypertensive effects alone, mediated by catecholamines via stimulation of myocardial alpha-and beta-adrenoceptors (9,10) or as a direct toxic effect on myocytes (11) (12) (13) (14) .
Due to the condition's rarity, studies of cardiac pathology in pheochromocytoma are mostly limited to case reports or series (1) , and the true underlying phenotype is not well-described. conditions (17, 18) . Thus, CMR provides a comprehensive means to characterize the cardiac phenotype in pheochromocytoma.
We performed the first prospective, systematic study to determine the extent of cardiac involvement in patients with pheochromocytoma using CMR. We hypothesized that cardiac involvement would be common and detectable using advanced tissue characterization techniques.
METHODS
This was a prospective study including 125 subjects: 
RESULTS
Baseline characteristics of patients with pheochromocytoma compared with matched control subjects are presented in Table 1 .
Newly diagnosed patients underwent CMR soon after diagnosis and before surgery (median 2 months;
IQR: 1 to 4 months). Most (97%) were in sinus rhythm, whereas 1 (3%) was in atrial fibrillation and another (3%) had frequent ectopy at the time of scan. Followup CMR was performed at a mean of 12 AE 5 months.
Previously diagnosed and cured patients underwent CMR examination at a median of 51 months (IQR: 27 to 83 months) from the date of surgical resection of their pheochromocytoma. All were in sinus rhythm at the time of scan. In this group, only those who had abnormal CMR findings (7 of 31, 23%)
were invited for a repeat CMR examination for followup (mean 25 AE 10 months; n ¼ 5).
CARDIAC FINDINGS USING CMR CHARACTERIZATION.
The CMR findings (Central Illustration, Figure 1 ) for each group of patients were compared with both healthy control subjects (age-and sex-matched) and hypertensive control subjects ( Table 1) .
Newly diagnosed patients had a lower mean left ventricular ejection fraction (LVEF) compared with both healthy and hypertensive control subjects
Catecholamine Myocarditis in Pheochromocytoma M A Y 2 4 , 2 0 1 6 : 2 3 6 4 -7 4 (both p < 0.05) ( Table 1) . On paired analysis, the average LVEF improved post-operatively in follow-up (from 60 AE 9% to 63 AE 5%; paired Student t test p <
0.03). Mild global LV dysfunction (LVEF 44% to 56%)
was seen in 38% (11 of 29) of patients, but typically normalized post-operatively by 1 year (63 AE 5%; range 54% to 70%) in all available for follow-up. At baseline, newly diagnosed patients had impaired peak systolic circumferential strain compared with healthy and hypertensive control subjects (both p < 0.05) ( Figure 2A , Table 1 ) and diastolic strain rate (both p < 0.05) ( Figure 2B , Table 1 ). These abnormalities persisted at follow-up on paired analyses (both p ¼ NS) ( Table 2) .
Patients with previously diagnosed and surgically cured pheochromocytoma had a normal mean LVEF (67 AE 5%; range 60% to 78%), which was higher than in newly diagnosed patients (60 AE 9%; p < 0.001), but no different from healthy or hypertensive control subjects (67 AE 4% for each respectively; both p ¼ NS).
Interestingly, despite having normal LVEF, these patients had slightly impaired peak systolic circumferential strain compared with healthy control subjects, but it was not different from hypertensive control subjects (p ¼ NS) ( Figure 2A , Table 1 ). Previously diagnosed patients had significantly more impaired diastolic strain rate compared with both healthy and hypertensive control subjects (all p < 0.001) ( Figure 2B , Table 1 ). This diastolic functional impairment was similar to that seen in newly diagnosed patients post-operatively in follow-up Other antihypertensive agents at time of CMR scan Angiotensin-converting enzyme inhibitor
Nondihydropyridine calcium-channel blocker
Thiazide diuretic agent LV myocardium with LGE >2 SD, % 5 (2-7)* 2 (0-5)
Values are mean AE SD, n (%), or median (interquartile range). *Significantly different from normal control subjects. †Significantly different from HTN control subjects (p < 0.05). ‡Significantly different from patients with a previous diagnosis of pheochromocytoma.
BSA ¼ body surface area; CMR ¼ cardiac magnetic resonance; Dx ¼ diagnosis; HTN ¼ hypertension; LGE ¼ late gadolinium enhancement; LV ¼ left ventricular.
Catecholamine Myocarditis in Pheochromocytoma
Of note, LVH was atypical in patients with pheochromocytoma. Newly diagnosed patients had a normal left ventricular mass index (LVMI) that was not significantly different from healthy or hypertensive control subjects (all p ¼ NS) ( Table 1) Cardiac magnetic resonance (CMR) imaging using advanced myocardial tissue characterization techniques was able to detect a wide range of abnormalities related to catecholamine cardiac toxicity in a live patient cohort with pheochromocytoma. These include (A) left ventricular dysfunction and pericardial effusion (arrow) (cine imaging, end-diastolic still frame); (B) subclinical systolic and diastolic dysfunction on strain parameters (tagged CMR; end-systolic still frame); (C) focal and diffuse fibrosis (LGE imaging demonstrating nonischemic midwall pattern of focal fibrosis) (arrow); and (D) catecholamine myocarditis (T 1 map showing elevated global myocardial T 1 values >990 ms). These changes appear to be beyond those seen in hypertensive heart disease alone, and some persisted over time.
LGE ¼ late gadolinium enhancement. control subjects ( Tables 1 and 2 ). Previously diagnosed patients had a normal LVMI compared with healthy control subjects (p ¼ NS) and a lower LVMI compared with hypertensive control subjects and newly diagnosed patients pre-operatively (both p < 0.05) ( Table 1) .
FOCAL MYOCARDIAL FIBROSIS (LGE IMAGING).
There was an increased incidence of focal myocardial fibrosis, as detected by LGE imaging, in patients both newly diagnosed and previously diagnosed with pheochromocytoma. In newly diagnosed patients, a significant proportion (59%; n ¼ 17) demonstrated scarring, all with a nonischemic pattern (midwall, subepicardial, or patchy), but these areas were small (median 5% of LV myocardium; IQR: 2% to 7%) and did not progress in size or distribution on follow-up.
Interestingly, the frequency of these scars was significantly higher than that seen in hypertensive control subjects (59% vs. 14%; p < 0.003), but the area of scarring tended to be small in both groups (median 5% vs. 2%; p ¼ 0.1).
In previously diagnosed patients, a smaller pro- Although we do not have verification via histopathological correlation, this hypothesis is an attractive explanation consistent with both human and animal histopathological studies and the natural history of this condition (1, 4, 6, 8, 22, 24, 26) .
Further, these myocardial abnormalities appear to be distinct from those of hypertensive heart disease or pressure overload alone. First, the catecholamineinduced pattern of hypertension is highly variable, often paroxysmal either on a background of sustained hypertension or normotension in between periods of hypertension (6). Second, blood pressure patterns also appear to be distinct from essential hypertension (10), with greater daytime variability and lack of a nocturnal dip (29, 30) , implying different mechanisms of hypertension, making it difficult to find matching control subjects (1) . Perhaps most convincing: although some studies have described an association between plasma norepinephrine levels and LVH (22, 31, 32) , only a subset (w25% to 40% of patients)
with pheochromocytoma demonstrated echocardiographic evidence of LVH in other studies (1, 6, (33) (34) (35) .
Our study demonstrated a similar lack of LVH in these patients, and we have carefully chosen hypertensive control subjects without severe LVH to more closely match the morphological LV phenotype of patients with pheochromocytoma; these patients demonstrated cardiac findings that are distinct from and Abbreviations as in Table 1 . STUDY LIMITATIONS. Due to the rarity of the condition, this study has a relatively small sample size, although it is the largest study to date using CMR as a phenotypic tool. Given that the changes are subclinical, larger studies are needed to confirm these findings and determine their long-term clinical significance. We recruited patients with pheochromocytoma mostly from the outpatient setting, so selection bias existed, and this study's findings characterize a more stable cohort without more severe cardiovascular complications (6) . Similar to other studies of patients with pheochromocytoma, it is difficult to find an appropriate hypertensive control group (4, 10) to match the variable patterns of hypertension in pheochromocytoma that seem to be distinct from those of essential hypertension and to clearly delineate which findings are attributable to hypertension alone, are attributable to catecholamine toxicity, or may be synergistic. Endomyocardial biopsy was not indicated in these patients, and as such, direct histopathological correlation to the imaging findings is not available.
CONCLUSIONS
Cardiac involvement was frequent and often persistent in pheochromocytoma, including myocarditis, Kingdom. E-mail: vanessa.ferreira@cardiov.ox.ac.uk.
